New Report Sheds Light on the Emerging Global Generic Drug market

PRLog (Press Release) - Jul 03, 2008 -
Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has added a new report which provides an up-to-date overview of the latest changes within the global generic market over the last 18 months.

The report “New Dynamics and Challenges in The Generics Market 2007”, available at http://tinyurl.com/5g2l7f offers an understanding of the current situation of the global generic drugs market and its key political, legislative, regulatory, operational and commercial developments. It enables the reader to respond to the opportunities and challenges this emerging markets present.

The report will help the reader gain insights into into the continuing global debate over patents, market exclusivity, drug pricing and compulsory licensing in light of the TRIPS (Trade-Related Aspects of Intellectual Property Rights) agreement and Doha Declaration.

Additionally, it informs about key issues affecting the industry such as tensions and authorised generics and “reverse” settlements. It also assesses the EU harmonisation of the generics market, usage patents, cost-containment and new pricing paradigms.

Furthermore, the report evaluates the impact biosimilars may have on the reader's market and what the current trend for consolidation amongst generics manufacturers means for the future.

The report “New Dynamics and Challenges in The Generics Market 2007” is available in pdf format from Piribo:
http://www.piribo.com/publications/generic_drugs/new_dyna...

Piribo product ID: SCR016

Photo:
http://www.prlog.org/10085868/1